Thc Biomed Intl Stock Performance
| THCBF Stock | USD 0.01 0 13.33% |
THC Biomed holds a performance score of 7 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of -7.14, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning THC Biomed are expected to decrease by larger amounts. On the other hand, during market turmoil, THC Biomed is expected to outperform it. Use THC Biomed Intl standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to analyze future returns on THC Biomed Intl.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in THC Biomed Intl are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, THC Biomed reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 111.2 K | |
| Total Cashflows From Investing Activities | 2.5 M |
THC |
THC Biomed Relative Risk vs. Return Landscape
If you would invest 1.30 in THC Biomed Intl on January 26, 2024 and sell it today you would earn a total of 0.06 from holding THC Biomed Intl or generate 4.62% return on investment over 90 days. THC Biomed Intl is currently producing 1.8189% returns and takes up 19.1218% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than THC, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
THC Biomed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for THC Biomed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as THC Biomed Intl, and traders can use it to determine the average amount a THC Biomed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0951
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | THCBF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.12 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.82 actual daily | 36 64% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average THC Biomed is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of THC Biomed by adding it to a well-diversified portfolio.
THC Biomed Fundamentals Growth
THC Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of THC Biomed, and THC Biomed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on THC Pink Sheet performance.
| Return On Equity | -0.41 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (1.56) % | |||
| Operating Margin | (1.83) % | |||
| Current Valuation | 6.56 M | |||
| Shares Outstanding | 163.96 M | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 1.37 X | |||
| Revenue | 3.34 M | |||
| EBITDA | (1.64 M) | |||
| Cash And Equivalents | 1.16 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 858.43 K | |||
| Debt To Equity | 0.56 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (1.86 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 14.75 M | |||
| Retained Earnings | (2.75 M) | |||
| Current Asset | 349 K | |||
| Current Liabilities | 648 K | |||
About THC Biomed Performance
To evaluate THC Biomed Intl Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when THC Biomed generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare THC Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand THC Biomed Intl market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents THC's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. THC Biomed Intl Ltd. was founded in 2012 and is headquartered in Kelowna, Canada. Thc Biomed is traded on OTC Exchange in the United States.Things to note about THC Biomed Intl performance evaluation
Checking the ongoing alerts about THC Biomed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for THC Biomed Intl help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| THC Biomed Intl is way too risky over 90 days horizon | |
| THC Biomed Intl has some characteristics of a very speculative penny stock | |
| THC Biomed Intl appears to be risky and price may revert if volatility continues | |
| The company has accumulated 858.43 K in total debt with debt to equity ratio (D/E) of 0.56, which is about average as compared to similar companies. THC Biomed Intl has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist THC Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, THC Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Biomed Intl sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Biomed's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 3.34 M. Net Loss for the year was (3.07 M) with loss before overhead, payroll, taxes, and interest of (1.03 M). | |
| THC Biomed Intl has accumulated about 1.16 M in cash with (1.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 29.0% of THC Biomed outstanding shares are owned by corporate insiders |
- Analyzing THC Biomed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether THC Biomed's stock is overvalued or undervalued compared to its peers.
- Examining THC Biomed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating THC Biomed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of THC Biomed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of THC Biomed's pink sheet. These opinions can provide insight into THC Biomed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in THC Biomed Intl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the THC Biomed Intl information on this page should be used as a complementary analysis to other THC Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for THC Pink Sheet analysis
When running THC Biomed's price analysis, check to measure THC Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Biomed is operating at the current time. Most of THC Biomed's value examination focuses on studying past and present price action to predict the probability of THC Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Biomed's price. Additionally, you may evaluate how the addition of THC Biomed to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |